HUSCAP logo Hokkaido Univ. logo

Hokkaido University Collection of Scholarly and Academic Papers >
医学研究院・医学院  >
雑誌発表論文等  >

Clinical and histopathological characteristics of patients with prostate cancer in the BioBank Japan project

この資料はクリエイティブ・コモンズ・ライセンスの下で公開されています。

フルテキスト
1-s2.0-S0917504016301058-main.pdf399.75 kBPDF見る/開く
この文献へのリンクには次のURLを使用してください:http://hdl.handle.net/2115/65816

タイトル: Clinical and histopathological characteristics of patients with prostate cancer in the BioBank Japan project
著者: Ukawa, Shigekazu 著作を一覧する
Nakamura, Koshi 著作を一覧する
Okada, Emiko 著作を一覧する
Hirata, Makoto 著作を一覧する
Nagai, Akiko 著作を一覧する
Yamagata, Zentaro 著作を一覧する
Muto, Kaori 著作を一覧する
Matsuda, Koichi 著作を一覧する
Ninomiya, Toshiharu 著作を一覧する
Kiyohara, Yutaka 著作を一覧する
Kamatani, Yoichiro 著作を一覧する
Kubo, Michiaki 著作を一覧する
Nakamura, Yusuke 著作を一覧する
BioBank Japan Cooperative Hospital Group 著作を一覧する
Tamakoshi, Akiko 著作を一覧する
キーワード: BioBank Japan project
Lifestyle
Prostate cancer
Survival
Tumor biomarker
発行日: 2017年 3月
出版者: Elsevier
誌名: Journal of epidemiology
巻: 27
号: 3, Supplement
開始ページ: S65
終了ページ: S70
出版社 DOI: 10.1016/j.je.2016.12.008
抄録: Background: Prostate cancer is the sixth leading cause of cancer-related deaths in Japan. We aimed to elucidate the clinical and histopathological characteristics of patients with prostate cancer in the BioBank Japan (BBJ) project. Methods: Four thousand, seven hundred and ninety-three patients diagnosed with prostate cancer in the BBJ project were included. Clinical and histopathological data, including causes of death, were analyzed. Relative survival (RS) rates of prostate cancer were calculated. Results: Four thousand, one hundred and seventy-one prostate cancer patients with available histological data had adenocarcinoma. The mean age of the patients was 72.5 years. The proportion of patients who were non-smokers, non-drinkers, had a normal body mass index, did not exercise, had a normal prostate-specific antigen level, and had a family history of prostate cancer were 30.7%, 28.0%, 66.6%, 58.1%, 67.6%, and 6.5%, respectively. The proportion of patients with Stage II, III, and IV disease were 24.4%, 7.3%, and 4.4%, respectively. After limiting to patients with a time from the initial diagnosis of prostate cancer to entry into the study cohort of ≤90 days (n = 869), the 5- and 10-year RS rates were 96.3% and 100.5%, respectively, although we were unable to consider management strategies due to a plenty of data missing. Conclusions: We provide an overview of patients with prostate cancer in the BBJ project. Our findings, coupled with those from various high throughput “omics” technologies, will contribute to the implementation of prevention interventions and medical management of prostate cancer patients.
資料タイプ: article
URI: http://hdl.handle.net/2115/65816
出現コレクション:雑誌発表論文等 (Peer-reviewed Journal Articles, etc)

提供者: 玉腰 暁子

 

本サイトに関するご意見・お問い合わせは repo at lib.hokudai.ac.jp へお願いします。 - 北海道大学